-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD) Drug Details: Atidarsagene autotemcel...
-
Product Insights
Net Present Value Model: Libmeldy
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Libmeldy Drug Details Atidarsagene autotemcel (libmeldy)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – atidarsagene autotemcel
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry atidarsagene autotemcel Drug Details Atidarsagene autotemcel (libmeldy) is a gene therapy containing an autologous...
-
Product Insights
Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of...